edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: Pixium Vision
Pixium Vision develops bionic vision systems for patients with severe vision loss. Its lead product, Prima, is a wireless sub-retinal implant system designed for Dry-ARMD. The company has completed a human feasibility study for Prima in Europe and expects to start implantations in a US feasibility study in H119.
Pixium Vision — 2 videos in collection
Pixium Vision develops bionic vision systems for patients with severe vision loss. Its lead product, Prima, is a wireless sub-retinal implant system designed for patients with geographic atrophy related to dry-AMD. The company started the PRIMAvera European pivotal study in late 2020, and top-line data are anticipated in early 2023.
In this interview, chief executive officer Lloyd Diamond and chief financial officer Offer Nonhoff discuss how Prima differentiates itself from earlier-generation retinal implants, and provide details on the ongoing PRIMAvera study as well as the planned commercial strategy for the US and key European markets. They also review the company’s financial position and objectives, and comment on longer-term development opportunities. Finally, the company’s executives highlight some of the key catalysts and milestones expected over the next year.
Get access to the very latest content matched to your personal investment style.